Connor, Clark & Lunn Investment Management (CC&L)’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-969
| Closed | -$520K | – | 1604 |
|
|
2025
Q2 | $520K | Buy |
+969
| New | +$463K | ﹤0.01% | 1246 |
|
|
2024
Q2 | – | Sell |
-663
| Closed | -$358K | – | 1517 |
|
|
2024
Q1 | $358K | Buy |
+663
| New | +$362K | ﹤0.01% | 1208 |
|
|
2022
Q4 | – | Sell |
-3,716
| Closed | -$1.21M | – | 1314 |
|
|
2022
Q3 | $1.21M | Sell |
3,716
-7,013
| -65% | -$2.58M | 0.01% | 607 |
|
|
2022
Q2 | $3.76M | Buy |
10,729
+7,311
| +214% | +$2.98M | 0.02% | 362 |
|
|
2022
Q1 | $1.87M | Buy |
3,418
+1,252
| +58% | +$659K | 0.01% | 515 |
|
|
2021
Q4 | $1.43M | Sell |
2,166
-1,638
| -43% | -$1.03M | 0.01% | 608 |
|
|
2021
Q3 | $2.37M | Sell |
3,804
-23,015
| -86% | -$15.5M | 0.01% | 491 |
|
|
2021
Q2 | $16.9M | Sell |
26,819
-6,781
| -20% | -$3.74M | 0.09% | 184 |
|
|
2021
Q1 | $16.4M | Buy |
33,600
+12,960
| +63% | +$6.49M | 0.09% | 173 |
|
|
2020
Q4 | $10.3M | Sell |
20,640
-210
| -1% | -$94K | 0.06% | 223 |
|
|
2020
Q3 | $8.2M | Buy |
20,850
+8,025
| +63% | +$2.97M | 0.05% | 228 |
|
|
2020
Q2 | $4.23M | Buy |
12,825
+11,220
| +699% | +$3.25M | 0.03% | 326 |
|
|
2020
Q1 | $389K | Sell |
1,605
-2,845
| -64% | -$742K | ﹤0.01% | 752 |
|
|
2019
Q4 | $1.16M | Buy |
4,450
+1,550
| +53% | +$408K | 0.01% | 521 |
|
|
2019
Q3 | $789K | Buy |
2,900
+1,650
| +132% | +$459K | 0.01% | 590 |
|
|
2019
Q2 | $344K | Buy |
+1,250
| New | +$308K | ﹤0.01% | 797 |
|
|
2018
Q4 | – | Sell |
-2,050
| Closed | -$512K | – | 990 |
|
|
2018
Q3 | $512K | Sell |
2,050
-8,300
| -80% | -$2.01M | ﹤0.01% | 695 |
|
|
2018
Q2 | $2.26M | Sell |
10,350
-1,400
| -12% | -$288K | 0.01% | 449 |
|
|
2018
Q1 | $2.25M | Sell |
11,750
-100
| -0.8% | -$18.5K | 0.01% | 375 |
|
|
2017
Q4 | $1.85M | Buy |
11,850
+5,600
| +90% | +$881K | 0.01% | 428 |
|
|
2017
Q3 | $972K | Buy |
6,250
+3,850
| +160% | +$609K | 0.01% | 535 |
|
|
2017
Q2 | $387K | Buy |
+2,400
| New | +$390K | ﹤0.01% | 644 |
|